Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck Buys Sigma-Aldrich for $17 billion
Digital Journal
Saturday, September 27, 2014 - 10:01am
tags:
Merck, Sigma-Aldrich, M&A
BioMotiv, Takeda Pharma enter into strategic partnership
PharmaBiz
Saturday, September 27, 2014 - 9:56am
tags:
BioMotiv, Takeda
Radiant/CRA Enroll 8,000 for Hepatitis B Vaccine Study
AZ Big Media
Saturday, September 27, 2014 - 9:51am
tags:
Radiant CRA, Dynavax, vaccines, hepatitis B
Early data promising for AstraZeneca cancer drug combination
Yahoo/Reuters
Saturday, September 27, 2014 - 9:35am
tags:
Astra Zeneca, MEDI4736, lung cancer
Alimera's eye implant Iluvien wins FDA approval
Yahoo/Reuters
Saturday, September 27, 2014 - 9:33am
tags:
Alimera, Iluvien, pSivida, diabetic macular edema
Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance
Yahoo/Zacks
Saturday, September 27, 2014 - 9:31am
tags:
Gilead Sciences, Tybost, Vitekta, HIV
Alnylam Starts New Study on Cardiac Amyloidosis Patients
Yahoo/Zacks
Saturday, September 27, 2014 - 9:28am
tags:
Alnylam, cardiac amyloidosis, ALN-TTRsc
MannKind and Sanofi Complete Afrezza Collaboration Deal
Yahoo/Zacks
Saturday, September 27, 2014 - 9:26am
tags:
MannKind, Sanofi, Afrezza, diabetes, type 2 diabetes
Can Gilead Sciences Be A Do-Gooder And Still Do Well?
Investor's.com
Saturday, September 27, 2014 - 9:23am
tags:
Gilead Sciences, Sovaldi
Agios' Early Drug-Trial Report Cheers Wall Street
Investors.com
Friday, September 26, 2014 - 3:57pm
tags:
Agios Pharmaceuticals, AG-120
Focusing Solely On Animal Health Sets Zoetis Apart
Investors.com
Friday, September 26, 2014 - 3:55pm
tags:
animal health, Zoetis
Genzyme to Collaborate on Gene Therapy for Blindness-Causing Diseas
Drug Discovery and Development
Friday, September 26, 2014 - 12:06pm
tags:
gene therapy, Genzyme, Sanofi
Takeda pours $25M into biotech dealmaker BioMotiv
Fierce Biotech
Friday, September 26, 2014 - 12:03pm
tags:
Takeda, BioMotiv, R&D
The 5 Best Biotech Stocks in 2014...so far
Motley Fool
Friday, September 26, 2014 - 11:42am
tags:
biotech, Intercept Pharmaceuticals, Achillion, Puma Biotechnology, PTC Therapeutics, Receptos
FDA Social Media Guides Draw Industry, User Criticism
Medical Marketing and Media
Friday, September 26, 2014 - 11:39am
tags:
FDA, social media
LabCorp Acquiring Cholesterol Tester LipoScience
Investors.com
Friday, September 26, 2014 - 11:35am
tags:
LapCorp, diagnostics, LipoScience, M&A
[video] Kite Pharma IPO Helping Fund Cancer-Drug Research: CEO
Bloomberg
Friday, September 26, 2014 - 11:32am
tags:
Kite Pharma, IPOs, cancer, R&D
Three Take-Home Messages from China's Glaxo Verdict
Forbes
Friday, September 26, 2014 - 11:04am
tags:
China, GSK
Valeant adds activist shareholder Ubben to board as Allergan takeover bid heats up
Fierce Pharma
Friday, September 26, 2014 - 10:55am
tags:
Valeant Pharmaceuticals, Allergan, M&A, Jeffrey Ubben
Fujifilm Says French Ebola Patient Taking Its Avigan Drug
Bloomberg
Friday, September 26, 2014 - 10:49am
tags:
ebola virus, Avigan, Fujifilm

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.